Association between CagA+ Helicobacter pylori infection and p53, BAX and transforming growth factor-B-RII gene mutations in gastric cancer patients

International Journal of Cancer

Volumn 91, Issue 4, 2001, Pages 481-485

  Deguchi, R ^a,b   Takagi, A ^a   Kawata, H ^a   Inoko, H ^a   Miwa, T ^a  

^a TOKAI UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CagA; Gastric cancer; Gene mutation

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; PROTEIN BAX; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CARCINOMA;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; CODON; DNA MUTATIONAL ANALYSIS; EXONS; GASTRIC MUCOSA; GENES, P53; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STOMACH NEOPLASMS;

EID: 0035866036     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1088>3.0.CO;2-B     Document Type: Article

References (37)

1. Cancer, p53, guardian of the genome
2. p53, the cellular gatekeeper for growth and division
3. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
4. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia
5. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: Analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP
6. 1 in the epidermis of transgenic mice
7. Mammary tumor suppression by transforming growth factor β1 transgene expression
8. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
9. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
10. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer
11. Mutations of the transforming growth factor-β type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer
12. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population
13. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis
14. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
15. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
16. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma
17. Mutations of K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy
18. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement
19. Diet Helicobacter pylori, and p53 mutations in gastric cancer: A molecular epidemiology study in Italy
20. Molecular alterations in early gastric carcinomas
21. Flagellin gene diversity among Helicobacter pylori strains and IL-8 secretion from gastric epithelial cells
22. K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines
23. Alterations of p53 gene in primary gastric cancer tissues
24. p53 alteration in gastric precancerous lesions
25. Helicobacter pylori infection and the risk for duodenal and gastric ulceration
26. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates
27. Helicobacter pylori and chronic gastritis
28. p53 expression in gastric cancer. Clinicopathological correlation and prognostic significance
29. Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma
30. Prognostic value of p53 protein expression for patients with gastric cancer: A multivariate analysis
31. Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
32. Genetic alterations in gastric cancer: Relation to histological subtypes, tumor stage, and Helicobacter pylori infection
33. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas
34. Transforming growth factor-β1 induces apoptosis in gastric cancer cells through a p53-independent pathway
35. Mutation of the transforming growth factor-β type II receptor gene is a rare event in human sporadic gastric carcinomas
36. 1 to S transition in AGS gastric epithelial cells